Zong et al. [22] and Makker et al. [26] utilized the Combined Positive Score (CPS) as the scoring algorithm, defined as the total number of PD-L1-positive cells (tumor cells, lymphocytes, and macrophages) divided by the total number of viable tumor cells within the evaluated area, multiplied by 100. The gene discussed is CD274; the disease is neoplasm.